UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 3, 2004
Commission file number 0-15701
NATURAL ALTERNATIVES INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
Delaware | 84-1007839 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
1185 Linda Vista Drive San Marcos, California 92069 |
(760) 744-7340 | |
(Address of principal executive offices, including zip code) |
(Registrants telephone number, including area code) |
Item 7. Financial Statements and Exhibits.
(c) | Exhibits. |
99.1 | Press release dated May 3, 2004 of the registrant |
Item 12. Results of Operations and Financial Condition.
On May 3, 2004, the registrant issued a press release announcing financial results for the third quarter ended March 31, 2004. A copy of this press release is attached hereto as Exhibit 99.1.
The information in this report and the exhibits hereto shall not be deemed to be filed for the purposes of Section 18 of the Securities and Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in this report shall not be incorporated by reference into any filing of the registrant with the SEC, whether made before or after the date hereof, regardless of any general incorporation language in such filings.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Natural Alternatives International, Inc. | ||||
Date: May 3, 2004 |
By: |
/s/ John R. Reaves | ||
John R. Reaves | ||||
Chief Financial Officer |
Exhibit 99.1
Natural Alternatives International, Inc. Reports Record Quarterly
Revenue and Net Income of $0.13 per Diluted Share for the
Third Quarter of Fiscal 2004
SAN MARCOS, CALIF, May 3, 2004 /PRNewswire/ Natural Alternatives International, Inc. (NAI) (Nasdaq: NAII), a leading formulator and manufacturer of customized nutritional supplements, reported net income of $855,000 or $0.13 per diluted share on revenue of $21.3 million for the quarter ended March 31, 2004.
Third quarter revenue increased 55% to $21.3 million from $13.8 million for the comparable quarter last year. Revenue growth resulted from a 68% increase in private label contract manufacturing sales partially offset by an 8% decrease in Direct-to-Consumer (DTC) sales. Income from operations increased to $1.0 million from $211,000 in the comparable quarter last year. Net income increased to $855,000 or $0.13 per diluted share from $172,000 or $0.03 per diluted share for the comparable quarter last year, representing an earning per share increase of 333%.
For the first nine months of fiscal 2004, revenue increased 38% to $55.2 million from $39.9 million for the comparable period last year. Revenue growth resulted from a 46% increase in private label contract manufacturing sales and a 3% increase in DTC sales. Income from operations increased to $2.2 million from $869,000 for the comparable period last year. Net income increased to $2.0 million or $0.32 per diluted share compared to $858,000 or $0.14 per diluted share in the comparable period last year, an increase of $1.1 million or $0.18 per diluted share. Excluding the effects of litigation settlement proceeds of $225,000 in the first quarter of the prior fiscal year, net income increased $1.4 million or $0.21 per diluted share.
As of March 31, 2004, NAI had cash and working capital of approximately $3.2 million and $14.2 million, respectively, compared to $5.5 million and $12.3 million, respectively, at June 30, 2003. During the first nine months of fiscal 2004, inventory increased $4.4 million in response to higher anticipated revenue. Additionally, $2.0 million was invested in capital expenditures for the first nine months of fiscal 2004. These expenditures were primarily continuing investment in our domestic manufacturing equipment.
Chairman and CEO Mark LeDoux commented, It is most gratifying to report record setting revenue in addition to robust earnings per share growth. Our investments in human and capital resources have yielded definite improvements in shareholder value. We anticipate continued revenue and earnings growth emanating from our commitments to excellence in product development, regulatory assistance, manufacturing and distribution in multiple channels around the globe.
President Randell Weaver commented, Recent additions to our product development and regulatory compliance capabilities demonstrate our continued focus on developing sustainable competitive advantages that can lead to long-term growth. In the third quarter we initiated our plans to build out and occupy newly leased 46,000 square feet of space contiguous to our existing manufacturing facility in Vista, California. We continue to evaluate expansion opportunities that could increase product lines, enhance our manufacturing capabilities or reduce risks associated with a variety of factors. In the near term we anticipate strengthening our capitalization through refinancing of our credit facilities.
NAI, headquartered in San Marcos, California, is a leading formulator and manufacturer of nutritional supplements and provides strategic partnering services to its customers. Our comprehensive partnership approach offers a wide range of innovative nutritional products and services to the client including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see our website at http://www.nai-online.com.
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our expectations and beliefs with respect to future financial and operating results and our ability to sustain profitability, maintain adequate financing, improve liquidity, maintain revenue growth, and implement our strategic plan. We wish to caution readers that these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAIs financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q.
SOURCE Natural Alternatives International, Inc.
CONTACT John R. Reaves, Chief Financial Officer, Natural Alternatives International, Inc.,
760-744-7340 or info@nai-online.com.
NATURAL ALTERNATIVES INTERNATIONAL, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
March 31, 2004 |
June 30, 2003 | |||||
(Unaudited) | ||||||
ASSETS |
||||||
Cash and cash equivalents |
$ | 3,162 | $ | 5,482 | ||
Accounts receivable, net |
6,329 | 5,668 | ||||
Inventories, net |
12,270 | 7,845 | ||||
Other current assets |
1,166 | 766 | ||||
Total current assets |
22,927 | 19,761 | ||||
Property and equipment, net |
10,804 | 10,820 | ||||
Other assets |
201 | 143 | ||||
Total Assets |
$ | 33,932 | $ | 30,724 | ||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||
Current liabilities |
$ | 8,731 | $ | 7,440 | ||
Long-term debt, less current installments |
1,955 | 2,386 | ||||
Long-term pension liability |
200 | 121 | ||||
Total Liabilities |
10,886 | 9,947 | ||||
Stockholders Equity |
23,046 | 20,777 | ||||
Total Liabilities and Stockholders Equity |
$ | 33,932 | $ | 30,724 | ||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
Three months ended March 31, |
Nine months ended March 31, | ||||||||||||||
2004 |
2003 |
2004 |
2003 | ||||||||||||
(Unaudited) | (Unaudited) | ||||||||||||||
NET SALES |
$ | 21,268 | $ | 13,755 | $ | 55,184 | $ | 39,901 | |||||||
Cost of goods sold |
16,215 | 10,468 | 42,090 | 30,367 | |||||||||||
Gross profit |
5,053 | 3,287 | 13,094 | 9,534 | |||||||||||
Selling, general & administrative expenses |
4,047 | 3,076 | 10,909 | 8,665 | |||||||||||
INCOME FROM OPERATIONS |
1,006 | 211 | 2,185 | 869 | |||||||||||
Other income (expense) |
(138 | ) | (33 | ) | (116 | ) | 10 | ||||||||
INCOME BEFORE INCOME TAXES |
868 | 178 | 2,069 | 879 | |||||||||||
Provision for income taxes |
13 | 6 | 71 | 21 | |||||||||||
NET INCOME |
$ | 855 | $ | 172 | $ | 1,998 | $ | 858 | |||||||
NET INCOME PER COMMON SHARE: |
|||||||||||||||
Basic |
$ | 0.15 | $ | 0.03 | $ | 0.34 | $ | 0.15 | |||||||
Diluted |
$ | 0.13 | $ | 0.03 | $ | 0.32 | $ | 0.14 | |||||||
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: |
|||||||||||||||
Basic shares |
5,848,841 | 5,814,258 | 5,830,508 | 5,807,143 | |||||||||||
Diluted shares |
6,335,462 | 6,061,391 | 6,201,686 | 6,004,304 | |||||||||||